| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |